Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell–cell adhesion and to suppress invasion

Abstract

E-cadherin germline missense mutations have been shown to be responsible for significant loss of protein activity. A new cytoplasmic E-cadherin germline missense mutation (V832 M) was recently identified in a hereditary diffuse gastric cancer (HDGC) Japanese family. This E-cadherin mutant was cloned in a Chinese hamster ovary cell model system and functionally characterized, in terms of aggregation and invasion. Cells expressing the germline V832M mutant fail to aggregate and invade into collagen, supporting the pathogenic role of this germline missense mutation in gastric cancer. We also tested the ability of this mutation to activate the TCF–LEF trascriptional activity, in comparison with three other E-cadherin missense mutations (T340A, A634V and A617T), associated to loss of E-cadherin function. All the E-cadherin mutants reduced TCF–LEF activation to a similar extent as the wild-type protein, suggesting that the oncogenic effect of the E-cadherin mutants is unlikely to be transmitted through a β-catenin-dependent activation of the WNT pathway.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

References

  • Anastasiadis PZ, Moon SY, Thoreson MA, Mariner DJ, Crawford HC, Zheng Y and Reynolds AB . (2000). Nat. Cell Biol., 2, 637–644.

  • Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR and Hofler H . (1994). Cancer Res., 54, 3845–3852.

  • Becker KF, Kremmer E, Eulitz M, Becker I, Handschuh G, Schuhmacher C, Muller W, Gabbert HE, Ochiai A, Hirohashi S and Hofler H . (1999). Am. J. Pathol., 155, 1803–1809.

  • Behrens J, Mareel MM, Van Roy FM and Birchmeier W . (1989). J. Cell Biol., 108, 2435–2447.

  • Berx G, Becker KF, Höfler H and Van Roy F . (1998). Hum. Mutat., 12, 226–237.

  • Bienz MM and Clevers H . (2000). Cell, 103, 311–320.

  • Boterberg T, Bracke ME, Bruyneel EA and Mareel MM . (2000). Methods in Molecular Medicine. Metastasis Research Protocols: Cell Behaviour In Vitro and In Vivo. Misc: Brooks SA and Shumacher U (eds). Humana Press: Totowa NJ, Misc: pp 33–45.

    Google Scholar 

  • Bradford MM . (1976). Anal. Biochem., 72, 248–254.

  • Bracke ME, Boterberg T, Bruyneel EA and Mareel MM . (2000). Methods in Molecular Medicine. Metastasis Research Protocols: Cell Behaviour in Vitro and in Vivo. Misc: Brooks SA and Shumacher U (eds). Humana Press: Totowa NJ, Misc: pp. 81–89.

    Google Scholar 

  • Cavallaro U, Schaffhauser B and Christofori G . (2002). Cancer Lett, 176, 123–128.

  • Chausovsky A, Bershadsky AD and Borisy GG . (2000). Nat. Cell Biol., 2, 797–804.

  • Chen H, Paradies NE, Fedor-Chaiken M and Brackenbury R . (1997). J. Cell Sci., 110, 345–356.

  • Christofori G and Semb H . (1999). Trends Biochem. Sci., 24, 73–76.

  • Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, Machado JC, Pinto E, Seruca R, Halling K, MacLeod P, Powell SM, Jackson CE, Ponder BA and Caldas C . (1998). Cancer Res., 58, 4086–4089.

  • Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A and Reeve AE . (1998). Nature, 392, 402–405.

  • Gumbiner BM (2000). J. Cell. Biol., 148, 399–404.

  • Handschuh G, Luber B, Hutzler P, Hofler P, Hofler H and Becker K . (2001). J. Mol. Biol., 314, 445–454.

  • Huber AH and Weis WI . (2001). Cell, 105, 391–402.

  • Machado JC, Oliveria C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F and Sobrinho-Simões M . (2001). Oncogene, 20, 1525–1528.

  • Oliveira C, Bordin MC, Grehan N, Huntsman D, Suriano G, Machado JC, Kiviluoto T, Aaltonen L, Jackson CE, Seruca R and Caldas C . (2002). Hum. Mutat., 19, 510–517.

  • Oliveira C, Seruca R and Caldas C . (2003). Expert Rev. Mol. Diagn., 3, 201–215.

  • Pertz O, Bozic D, Koch AW, Fauser C, Brancaccio A and Engel J . (1999). EMBO J., 18, 1738–1747.

  • Polakis P . (2000). Genes Dev., 14, 1837–1851.

  • Shapiro L, Fannon AM, Kwong PD, Thompson A, Lehmann MS, Grubel G, Legrand JF, Als-Nielsen J, Colman DR and Hendrickson WA . (1995). Nature, 374, 327–337.

  • Shore EM and Nelson WJ . (1991). J. Biol. Chem., 266, 19672–19680.

  • Suriano G, Oliveira C, Ferreira P, Machado JC, Bordin MC, De Wever O, Bruyneel EA, Moguilevsky N, Grehan N, Porter TR, Richards FM, Hruban RH, Roviello F, Huntsman D, Mareel M, Carneiro F, Caldas C and Seruca R . (2003). Hum. Mol. Genet., 12, 575–582.

  • Thiery JP . (2002). Nat. Rev. Cancer, 2, 442–454.

  • Van Aken E, De Wever O, Correia da Rocha AS and Mareel M . (2001). Virchows Arch., 439, 725–751.

  • Van de Wetering M, Barker N, Harkes IC, van der Heyden M, Dijk NJ, Hollestelle A, Klijn JG, Clevers H and Schutte M . (2001). Cancer Res., 61, 278–284.

  • Vésey-Sémjen B, Becker KF, Sinski A, Blennow E, Vietor I, Zatloukal K, Beug H, Wagner E and Huber LA . (2002). Oncogene, 21, 4646–4662.

  • Yabuta T, Shinmura K, Tani M, Yamaguchi S, Yoshimura K, Katai H, Nakajima T, Mochiki E, Tsujinaka T, Takami M, Hirose K, Yamaguchi A, Takenoshita S and Yokota J . (2002). J. Int. J. Cancer, 101, 434–441.

Download references

Acknowledgements

This study was funded by grants from: Fundação para a Ciência e a Tecnologia, Portugal (Project: POCTI/35374/CBO/2000 and POCTI/CBO/40820/2001); FORTIS Verzekerngen and the Fund for Scientific Research – Flanders (FWO), Brussels, Belgium.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raquel Seruca.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suriano, G., Mulholland, D., de Wever, O. et al. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell–cell adhesion and to suppress invasion. Oncogene 22, 5716–5719 (2003). https://doi.org/10.1038/sj.onc.1206672

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206672

Keywords

This article is cited by

Search

Quick links